FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jens Rengelshausen

Research Profile

Concepts & Ideas

Chemicals & Drugs

Procedures

Disorders

Falciparum Malaria

Physiology

Genes & Molecular Sequences

Alleles

Geographic Areas

Burkina Faso

Co-author Network

Publications

TOP 3
Karin Göhler; Jens Rengelshausen; Johan W Smit; Martin Brett; Rolf Terlinden
Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
Johan W Smit; Charles Oh; Jens Rengelshausen; Rolf Terlinden; Paulien G M Ravenstijn; Shean-Sheng Wang; David Upmalis; Bernhard Mangold
Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.
Johanna Weiss; Magdalena Maria Ten Hoevel; Jürgen Burhenne; Ingeborg Walter-Sack; Michael M Hoffmann; Jens Rengelshausen; Walter E Haefeli; Gerd Mikus
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jens Rengelshausen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Karin Göhler; Jens Rengelshausen; Johan W Smit; Martin Brett; Rolf Terlinden
Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
International journal of clinical pharmacology and therapeutics 2013;51(4):338-48.
2010: Johan W Smit; Charles Oh; Jens Rengelshausen; Rolf Terlinden; Paulien G M Ravenstijn; Shean-Sheng Wang; David Upmalis; Bernhard Mangold
Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.
Pharmacotherapy 2010;30(1):25-34.
2009: Johanna Weiss; Magdalena Maria Ten Hoevel; Jürgen Burhenne; Ingeborg Walter-Sack; Michael M Hoffmann; Jens Rengelshausen; Walter E Haefeli; Gerd Mikus
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.
Journal of clinical pharmacology 2009;49(2):196-204.
2009: Ingeborg Walter-Sack; Jens Rengelshausen; Heike Oberwittler; Jürgen Burhenne; Olaf Mueller; Peter Meissner; Gerd Mikus
High absolute bioavailability of methylene blue given as an aqueous oral formulation.
European journal of clinical pharmacology 2009;65(2):179-89.
2008: Jürgen Burhenne; Klaus-Dieter Riedel; Jens Rengelshausen; Peter E Meissner; Olaf Müller; Gerd Mikus; Walter E Haefeli; Ingeborg Walter-Sack
Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;863(2):273-82.
2007: Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid.
International journal of clinical pharmacology and therapeutics 2007;45(8):431-7.
2007: M Stiefel; T Reiss; Martin Staege; Jens Rengelshausen; Jürgen Burhenne; A Wawer; Juergen Foell
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
Pediatric blood & cancer 2007;49(2):203-7.
2006: Jens Rengelshausen; Bernd Beedgen; Konstantina Tsamouranis; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli; Otwin Linderkamp
Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age.
European journal of clinical pharmacology 2006;62(9):773-7.
2006: Gerd Mikus; Verena Schöwel; Magdalena Drzewinska; Jens Rengelshausen; Reinhard Ding; Klaus-Dieter Riedel; Jürgen Burhenne; Johanna Weiss; Torben Thomsen; Walter E Haefeli
Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
Clinical pharmacology and therapeutics 2006;80(2):126-35.
2006: Peter E Meissner; Germain Mandi; Boubacar Coulibaly; Steffen Witte; Théophile Tapsoba; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; R Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine.
Malaria journal 2006;5():84.
2006: Christina Hoecker; Mathias Nelle; Bernd Beedgen; Jens Rengelshausen; Otwin Linderkamp
Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants.
Archives of disease in childhood. Fetal and neonatal edition 2006;91(1):F61-4.
2005: Jens Rengelshausen; Maria Banfield; Klaus-Dieter Riedel; Jürgen Burhenne; Johanna Weiss; Torben Thomsen; Ingeborg Walter-Sack; Walter E Haefeli; Gerd Mikus
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.
Clinical pharmacology and therapeutics 2005;78(1):25-33.
2005: Peter E Meissner; Germain Mandi; Steffen Witte; Boubacar Coulibaly; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Mamadou Sanon; Théophile Tapsoba; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
Malaria journal 2005;4():45.
2005: Germain Mandi; Steffen Witte; Peter E Meissner; Boubacar Coulibaly; Ulrich Mansmann; Jens Rengelshausen; Wolfgang Schiek; Albrecht Jahn; Mamadou Sanon; Kirsten Wüst; Ingeborg Walter-Sack; Gerd Mikus; Jürgen Burhenne; Klaus-Dieter Riedel; Heiner Schirmer; Bocar Kouyaté; Olaf Müller
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
Tropical medicine & international health : TM & IH 2005;10(1):32-8.
2005: Meret Martin-Facklam; Jens Rengelshausen; Yorki Tayrouz; Nahal Ketabi-Kiyanvash; Heike Lindenmaier; Verena Schneider; Verena Bergk; Walter E Haefeli
Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?
European journal of clinical pharmacology 2005;60(11):807-11.
2004: Jens Rengelshausen; Jürgen Burhenne; Margit Fröhlich; Yorki Tayrouz; Shio Kumar Singh; Klaus-Dieter Riedel; Olaf Müller; Torsten Hoppe-Tichy; Walter E Haefeli; Gerd Mikus; Ingeborg Walter-Sack
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria.
European journal of clinical pharmacology 2004;60(10):709-15.
2004: Jens Rengelshausen; Heike Lindenmaier; Tomas Cihlar; Ingeborg Walter-Sack; Walter E Haefeli; Johanna Weiss
Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine.
Biochemical and biophysical research communications 2004;320(1):90-4.
2003: Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
British journal of clinical pharmacology 2003;56(1):32-8.
2002: Jens Rengelshausen; William E Hull; Vedat Schwenger; Christoph Göggelmann; Ingeborg Walter-Sack; Jürgen Bommer
Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(2):E10.